GrowthCurve acquires controlling stake in TailorMed in USD250m deal
GrowthCurve Capital has agreed to acquire a controlling stake in Israeli digital health company TailorMed in a transaction valued at approximately USD 250 million. Most of TailorMed’s existing shareholders are expected to sell their holdings as part of the deal.
Founded in 2016, TailorMed operates a technology platform designed to help US patients overcome financial and administrative barriers to accessing medication. Its network connects more than 950 hospitals, 4,700 clinics, and 3,100 pharmacies and reaches more than 75 million patients.
The investment is intended to support TailorMed’s next stage of growth, including new services and greater use of AI. The company also plans to broaden its platform beyond financial assistance, connecting patients, hospitals, pharmacies, and pharmaceutical companies across more of the treatment journey.
Herzog advised TailorMed together with Morrison Foerster. The Herzog team included Yoni Frider, Mor Limanovich, Dan Sharot, Shachar Porat, Liat Shaked-Katz, Dr. Ehab Farah, Ofer Granot, Dan Shalev, Gabriel Cohen, Natan Kaufman, Shahaf Efrati, Dor Furer, Daniella Weiss, Tal Habas, and Shiraz Davidi.
Paul, Weiss advised GrowthCurve Capital.
